RxDoctor Payments Data

Jennifer Stodden, PA

Physician Assistant · Onawa, IANPI 1730185604

Payments from drug & device makers

$2,930in general payments, 2019–2025

Across 181 payments — averaging $16.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$508
  • Amgen$150
  • Otsuka America Pharmaceutical, Inc.$148
  • Lundbeck LLC$145
  • Pfizer$140
  • Novo Nordisk$131
  • plus $2K from 41 others

What the payments were for

  • Food & beverage$2,930100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,930 in reported general payments places this provider in the 90th percentile of 1,140 physician assistant providers in Iowa.

See all physician assistant providers in Iowa

Medicare billing

Part B allowed, 2024
$8,558
Medicare patients
32
Services billed
216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide59$55,771
EliquisApixaban66$46,997
JardianceEmpagliflozin42$41,388
TrintellixVortioxetine Hydrobromide38$20,035
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$19,554
Tresiba Flextouch U-200Insulin Degludec14$19,190
Tresiba Flextouch U-100Insulin Degludec24$18,486
Breo ElliptaFluticasone/Vilanterol28$16,793
MounjaroTirzepatide11$12,401
FarxigaDapagliflozin Propanediol18$12,126
SymbicortBudesonide/Formoterol Fumarate18$4,235
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen71$2,187
Duloxetine Hcl78$2,030
Albuterol Sulfate HfaAlbuterol Sulfate30$1,564
Atorvastatin Calcium197$1,357

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$131$55,77159 claims
PfizerEliquis$140$46,99766 claims
Boehringer IngelheimJardiance$70$41,38842 claims
GSKTrelegy Ellipta, Breo Ellipta$31$36,34651 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$12$20,03538 claims
AstraZenecaFarxiga, Symbicort$86$16,36236 claims
Lilly USA, LLCMounjaro$37$12,40111 claims
AbbVieSynthroid$508$73415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,140 physician assistant providers in Iowa.

Other physician assistant in Onawa

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →